| ECM-receptor interaction |
1.73 |
2.30e-1 |
80/88 (90.91%) |
THBS1;COL4A3;THBS4;...
|
| Focal adhesion |
1.63 |
3.53e-1 |
180/201 (89.55%) |
SRC;THBS1;MYL9;...
|
| Relaxin signaling pathway |
1.32 |
6.14e-1 |
114/129 (88.37%) |
SRC;GNG4;COL4A3;...
|
| Cell cycle |
1.26 |
6.15e-1 |
110/124 (88.71%) |
PLK1;TGFB1;HDAC1;...
|
| Proteoglycans in cancer |
1.25 |
6.14e-1 |
172/205 (83.9%) |
SRC;THBS1;CAV2;...
|
| Amoebiasis |
1.25 |
5.91e-1 |
99/102 (97.06%) |
CTSG;COL4A3;TGFB1;...
|
| Oxytocin signaling pathway |
1.24 |
6.06e-1 |
128/154 (83.12%) |
SRC;NFATC3;MYL9;...
|
| GABAergic synapse |
1.23 |
6.15e-1 |
76/89 (85.39%) |
SRC;GNG4;GNG11;...
|
| Oocyte meiosis |
1.23 |
5.99e-1 |
90/129 (69.77%) |
RPS6KA2;PLK1;ITPR3;...
|
| Arrhythmogenic right ventricular cardiomyopathy |
1.22 |
5.94e-1 |
70/77 (90.91%) |
ITGA4;TCF7L2;LAMA2;...
|
| Pathogenic Escherichia coli infection |
1.21 |
6.05e-1 |
152/197 (77.16%) |
SRC;CLDN10;MYO6;...
|
| Alcoholism |
1.21 |
6.05e-1 |
86/186 (46.24%) |
GNG4;GNG11;HDAC1;...
|
| Transcriptional misregulation in cancer |
1.21 |
5.93e-1 |
158/192 (82.29%) |
PROM1;WT1;NSD2;...
|
| Phagosome |
1.21 |
5.75e-1 |
118/152 (77.63%) |
THBS1;TUBB2A;CALR;...
|
| Tight junction |
1.20 |
5.89e-1 |
130/169 (76.92%) |
SRC;CLDN10;MYL9;...
|
| IL-17 signaling pathway |
1.18 |
6.19e-1 |
84/94 (89.36%) |
LCN2;MUC5B;CEBPB;...
|
| Sulfur relay system |
1.18 |
6.02e-1 |
5/8 (62.5%) |
MPST;TST;NFS1;...
|
| Hypertrophic cardiomyopathy |
1.17 |
6.04e-1 |
81/90 (90%) |
TGFB1;ITGA4;TPM1;...
|
| Arginine and proline metabolism |
1.15 |
6.21e-1 |
39/50 (78%) |
GATM;SRM;ALDH18A1;...
|
| PI3K-Akt signaling pathway |
1.14 |
6.22e-1 |
317/354 (89.55%) |
THBS1;GNG4;COL4A3;...
|
| Human T-cell leukemia virus 1 infection |
1.13 |
6.18e-1 |
197/219 (89.95%) |
NFATC3;CALR;TGFB1;...
|
| Thyroid hormone signaling pathway |
1.13 |
6.08e-1 |
112/121 (92.56%) |
SRC;HDAC1;FXYD2;...
|
| Base excision repair |
1.12 |
6.13e-1 |
29/33 (87.88%) |
NEIL3;LIG1;POLE2;...
|
| Purine metabolism |
1.12 |
6.06e-1 |
102/129 (79.07%) |
ENPP1;PRPS2;GUCY1B1;...
|
| Other types of O-glycan biosynthesis |
1.11 |
6.17e-1 |
29/47 (61.7%) |
ST6GAL1;GALNT10;GALNT6;...
|
| Hedgehog signaling pathway |
1.11 |
6.23e-1 |
43/56 (76.79%) |
GAS1;IQCE;CCND1;...
|
| Sulfur metabolism |
1.11 |
6.11e-1 |
9/10 (90%) |
SQOR;PAPSS2;MPST;...
|
| Human cytomegalovirus infection |
1.11 |
6.08e-1 |
201/225 (89.33%) |
SRC;NFATC3;GNG4;...
|
| Melanoma |
1.10 |
6.20e-1 |
68/72 (94.44%) |
PDGFRA;PDGFRB;EGF;...
|
| cGMP-PKG signaling pathway |
1.10 |
6.11e-1 |
145/167 (86.83%) |
NFATC3;MYL9;ITPR3;...
|
| Staphylococcus aureus infection |
-1.33 |
4.92e-1 |
72/95 (75.79%) |
HLA-DRA;FPR1;CFI;...
|
| HIF-1 signaling pathway |
-1.34 |
4.65e-1 |
105/109 (96.33%) |
MAP2K1;ENO3;ELOC;...
|
| Intestinal immune network for IgA production |
-1.34 |
4.74e-1 |
38/48 (79.17%) |
HLA-DQB1;TNFRSF17;HLA-DOA;...
|
| Antigen processing and presentation |
-1.35 |
4.68e-1 |
60/78 (76.92%) |
HLA-DQB1;KLRD1;RFXANK;...
|
| Taurine and hypotaurine metabolism |
-1.35 |
4.78e-1 |
8/11 (72.73%) |
GAD1;GAD2;BAAT;...
|
| Synaptic vesicle cycle |
-1.35 |
4.86e-1 |
63/78 (80.77%) |
CLTB;ATP6V0E1;SLC6A12;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.36 |
4.87e-1 |
49/77 (63.64%) |
ADH7;CYP2C9;GSTK1;...
|
| Inflammatory bowel disease |
-1.36 |
5.07e-1 |
58/65 (89.23%) |
IL4R;HLA-DRA;IL18;...
|
| Inositol phosphate metabolism |
-1.37 |
4.80e-1 |
66/73 (90.41%) |
INPP5B;PIK3CB;PIK3CD;...
|
| Protein processing in endoplasmic reticulum |
-1.41 |
3.64e-1 |
127/171 (74.27%) |
MAN1B1;DERL1;FBXO2;...
|
| Melanogenesis |
-1.42 |
3.53e-1 |
74/101 (73.27%) |
TCF7L1;CREBBP;CALML3;...
|
| Cytokine-cytokine receptor interaction |
-1.43 |
3.40e-1 |
246/295 (83.39%) |
TNFRSF17;IL7;TNFRSF1A;...
|
| Other glycan degradation |
-1.44 |
3.19e-1 |
13/18 (72.22%) |
HEXA;HEXB;NEU1;...
|
| Folate biosynthesis |
-1.46 |
3.11e-1 |
23/26 (88.46%) |
MOCS1;ALPG;MOCS2;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.47 |
2.85e-1 |
62/70 (88.57%) |
ATP6V1H;ATP6V1B2;JUN;...
|
| Vibrio cholerae infection |
-1.49 |
2.77e-1 |
44/50 (88%) |
ATP6V1H;ATP6V1B2;SEC61B;...
|
| Hematopoietic cell lineage |
-1.51 |
2.26e-1 |
90/99 (90.91%) |
CD36;HLA-DQB1;IL7;...
|
| Toll-like receptor signaling pathway |
-1.56 |
1.68e-1 |
94/104 (90.38%) |
LBP;CCL4;MAPK9;...
|
| Renin-angiotensin system |
-1.56 |
1.82e-1 |
20/23 (86.96%) |
CPA3;KLK2;PRCP;...
|
| Rheumatoid arthritis |
-1.56 |
1.93e-1 |
78/93 (83.87%) |
HLA-DQB1;TEK;HLA-DOA;...
|
| Allograft rejection |
-1.58 |
1.75e-1 |
32/38 (84.21%) |
HLA-DQB1;HLA-DOA;HLA-DOB;...
|
| Autoimmune thyroid disease |
-1.62 |
1.40e-1 |
46/53 (86.79%) |
CD86;TSHR;HLA-DRA;...
|
| Viral protein interaction with cytokine and cytokine re... |
-1.65 |
1.27e-1 |
84/100 (84%) |
CCR3;PPBP;IL10RA;...
|
| Renin secretion |
-1.66 |
1.33e-1 |
61/69 (88.41%) |
EDN3;PTGER4;PPP3CA;...
|
| African trypanosomiasis |
-1.68 |
1.30e-1 |
32/37 (86.49%) |
IL18;IL1B;IL6;...
|
| Mineral absorption |
-1.69 |
1.35e-1 |
48/60 (80%) |
SLC31A1;TF;SLC30A1;...
|
| Oxidative phosphorylation |
-1.72 |
1.28e-1 |
93/133 (69.92%) |
NDUFB2;NDUFA9;ATP5PF;...
|
| Collecting duct acid secretion |
-1.72 |
1.71e-1 |
22/27 (81.48%) |
ATP6V0E1;ATP4A;TCIRG1;...
|
| Primary immunodeficiency |
-1.76 |
1.57e-1 |
33/38 (86.84%) |
LCK;RAG1;RFXANK;...
|
| Graft-versus-host disease |
-1.81 |
1.52e-1 |
32/42 (76.19%) |
HLA-DQB1;KLRD1;HLA-DOA;...
|
